Kenneth Ouriel, MD, MBA, President & CEO
For Dr. Kenneth Ouriel, President and CEO of Syntactx, laying the foundation for a full-service, innovative, and technology-driven CRO went hand in hand with his mission to elevate the standards for global health. To the good doctor, this was not just a business decision, but a continuation of his career as an academic vascular surgeon. His initial thoughts on establishing a quality driven CRO came when he served as the Chief of Vascular Surgery and later as Chairman of Surgery at the Cleveland Clinic, Ohio. What began as a small organization under his leadership, Syntactx has grown into a leading contract research organization that maintains the integrity, ethics, and values upon which it was founded. “We deliver the highest quality clinical research services based on a well-defined strategy, collaboration, and transparency, thereby reducing time to execution and minimizing executional risk for our clients,” states Ouriel.
With technology at its crux and a team of dedicated physicians at the helm who truly partner with clients, Syntactx offers the very best-in-class service. The company presents a “we are here for you” relationship in their interactions with clients rather giving them a transaction based experience. “Syntactx is the one clinical research organization clients can count on, to move their clinical evidence from benchtop to bedside,” says Ouriel.
Syntactx is primarily engaged in complex clinical trials involving medical devices and interventional therapeutics. They also have hands-on experience in pharmaceutical trials such as combination therapies. Right from protocol development to medical writing, the company provides a variety of services tailored to meet the specific needs of their clients. From the inception of a product to market introduction and post-market studies, the company offers clinical trials and support throughout the lifecycle of the product. They prepare their clients to pass the most stringent of requirements to gain global regulatory approval. In order to optimize clinical project management, the company leverages a seasoned team that understands how to handle elements involved in meeting the varied needs of sponsors, investigators, site research staff, regulators, and study subjects.
We deliver the highest quality clinical research services based on a well-defined strategy, collaboration, and transparency, thereby reducing time to execution and minimizing executional risk for our clients
An endorsement to their top-notch technology is the sophisticated core laboratory facility operated by an experienced and knowledgeable staff, producing precise and top tier results. Encompassing a variety of modalities including arterial and venous angiography, echocardiography, and CT and MR to name just a few, Syntactx serves as an exemplary model of investigative health care. Syntactx utilizes proprietary, web-based, secure image transfer methods and 3D rendering software to ensure that their imaging analysis capabilities remain on the cutting edge of technology.
Syntactx’s expertise in the CRO landscape is better understood with one of the projects they completed recently. A medical device manufacturing startup approached them with a device that helps in the treatment for aortic aneurysms. The client company was also planning to get acquired by a key player in their sector and the only way to get that done was to complete the clinical trials. The client confidently handed over the project to Syntactx, who was able to enroll more than 100 patients over the course of four years. The results of the trials were outstanding and helped to expand treatment options for patients suffering from aneurysms. A multi-national manufacturer since acquired the company.
They have recently made available Syncrony EDC, a bespoke clinical trial electronic data capture product. The product developed by researchers, for researchers, is powered by years of clinical trial experience, thought leader subject expertise, and a global network of key industry influencers. Syntactx has also inaugurated a new organization Syntactx Technologies which focuses on delivering SaaS clinical solutions. With a vision to become a partner of choice in bringing the most transformative therapies to patients around the world, they continue to expand their business both technologically and geographically.